These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19464121)

  • 1. Marijuana discontinuation, anxiety symptoms, and relapse to marijuana.
    Bonn-Miller MO; Moos RH
    Addict Behav; 2009 Sep; 34(9):782-5. PubMed ID: 19464121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anxiety sensitivity interacts with marijuana use in the prediction of anxiety symptoms and panic-related catastrophic thinking among daily tobacco users.
    Zvolensky MJ; Bonn-Miller MO; Bernstein A; McLeish AC; Feldner MT; Leen-Feldner EW
    Behav Res Ther; 2006 Jul; 44(7):907-24. PubMed ID: 16122698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nefazodone decreases anxiety during marijuana withdrawal in humans.
    Haney M; Hart CL; Ward AS; Foltin RW
    Psychopharmacology (Berl); 2003 Jan; 165(2):157-65. PubMed ID: 12439626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
    Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
    Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do trauma history and PTSD symptoms influence addiction relapse context?
    Norman SB; Tate SR; Anderson KG; Brown SA
    Drug Alcohol Depend; 2007 Sep; 90(1):89-96. PubMed ID: 17459611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marijuana coping motives interact with marijuana use frequency to predict anxious arousal, panic related catastrophic thinking, and worry among current marijuana users.
    Bonn-Miller MO; Zvolensky MJ; Bernstein A; Stickle TR
    Depress Anxiety; 2008; 25(10):862-73. PubMed ID: 17849459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of the history of a marijuana withdrawal syndrome in a large population.
    Wiesbeck GA; Schuckit MA; Kalmijn JA; Tipp JE; Bucholz KK; Smith TL
    Addiction; 1996 Oct; 91(10):1469-78. PubMed ID: 8917915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychiatric aspects of cannabis use in adolescents and young adults.
    Tunving K
    Pediatrician; 1987; 14(1-2):83-91. PubMed ID: 3497393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cannabis withdrawal syndrome.
    Budney AJ; Hughes JR
    Curr Opin Psychiatry; 2006 May; 19(3):233-8. PubMed ID: 16612207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mental health symptoms and their relationship to cannabis use in adolescents attending residential treatment.
    Albertella L; Norberg MM
    J Psychoactive Drugs; 2012; 44(5):381-9. PubMed ID: 23457889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms.
    Budney AJ; Vandrey RG; Hughes JR; Moore BA; Bahrenburg B
    Drug Alcohol Depend; 2007 Jan; 86(1):22-9. PubMed ID: 16769180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Withdrawal symptoms do not predict relapse among subjects treated for cannabis dependence.
    Arendt M; Rosenberg R; Foldager L; Sher L; Munk-Jørgensen P
    Am J Addict; 2007; 16(6):461-7. PubMed ID: 18058411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are diagnostic orphans at risk of developing cannabis abuse or dependence? Four-year follow-up of young adult cannabis users not meeting diagnostic criteria.
    Degenhardt L; Coffey C; Carlin JB; Swift W; Patton GC
    Drug Alcohol Depend; 2008 Jan; 92(1-3):86-90. PubMed ID: 17716830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Induced psychiatric and somatic disorders to cannabis].
    Laqueille X; Launay C; Kanit M
    Ann Pharm Fr; 2008 Aug; 66(4):245-54. PubMed ID: 18847572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychological deficits in long-term frequent cannabis users.
    Accordino M; Hart CL
    Neurology; 2006 Nov; 67(10):1902; author reply 1902. PubMed ID: 17130442
    [No Abstract]   [Full Text] [Related]  

  • 16. Abstinence and moderate use goals in the treatment of marijuana dependence.
    Lozano BE; Stephens RS; Roffman RA
    Addiction; 2006 Nov; 101(11):1589-97. PubMed ID: 17034438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Cannabis Withdrawal Scale development: patterns and predictors of cannabis withdrawal and distress.
    Allsop DJ; Norberg MM; Copeland J; Fu S; Budney AJ
    Drug Alcohol Depend; 2011 Dec; 119(1-2):123-9. PubMed ID: 21724338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of relapse to substance use in comorbid adolescents.
    Ramo DE; Anderson KG; Tate SR; Brown SA
    Addict Behav; 2005 Oct; 30(9):1811-23. PubMed ID: 16139961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Social anxiety and problematic cannabis use: evaluating the moderating role of stress reactivity and perceived coping.
    Buckner JD; Schmidt NB; Bobadilla L; Taylor J
    Behav Res Ther; 2006 Jul; 44(7):1007-15. PubMed ID: 16168950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lithium carbonate in the management of cannabis withdrawal in humans: an open-label study.
    Winstock AR; Lea T; Copeland J
    J Psychopharmacol; 2009 Jan; 23(1):84-93. PubMed ID: 18515451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.